PAA 8.89% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-17

  1. 2,236 Posts.
    lightbulb Created with Sketch. 2742
    By my understanding, FDA feedback is due on the Pre-Investigational New Drug (Pre-IND) meeting ( guaranteed ) by next Tuesday (FDA has committed to provide written responses by 13 February 2024) , and first dose on extension study must be any day.
    2 bits of news , literally, at any moment ... wouldn't you wait for these to drop, at the very least, and sell into that news.

    Go figure ....

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.020(8.89%)
Mkt cap ! $81.16M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $331.9K 1.617M

Buyers (Bids)

No. Vol. Price($)
4 440882 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 12736 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.